In conclusion, this study provides insights into the in vivo metabolic profile of CML and highlights the dominant role of sphingolipid metabolism in BCR::ABL1-induced metabolic reprogramming. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.